Clinical Trial

A Single-Arm, Open-Label, Phase I Study of GK01 for Advanced Solid Tumor

Name: A Single-Arm, Open-Label, Phase I Study of GK01 for Advanced Solid Tumor — clinical trial record (NCT06954558)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: GUARDIAN

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This study is a Phase I, open-label, single-arm clinical trial to evaluate the safety, pharmacokinetics, and preliminary efficacy of GK01 in patients with advanced solid tumors.

Trial Details

NCT Number	NCT06954558
Lead Sponsor	Tianjin Medical University Cancer Institute and Hospital Collaborators: Beijing Geekgene Technology Co., LTD
Conditions	Advanced Solid Tumors
Enrollment	15 participants
Start Date	2025-03-18
Primary Completion	2028-03-18 (estimated)
Study Completion	2028-07-18 (estimated)
Updated on ClinicalTrials.gov	2025-05-01